Delivery Order SPE2DB22D1103-SPE2DB25FTQB6

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,686.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,248,680 units of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,534.14 delivery order contract is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a specialty medication. The contract has a firm fixed price pricing type and a period of performance through February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,345.30, is a delivery order for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has a period of performance through June 6, 2024 and uses a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567360089 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has an ultimate completion date of February 25, 2025 and a ceiling value of $1,703.76. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,164.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a medical product, with a completion date of June 10, 2025. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,095.29, is a delivery order for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,325.36, is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML medical supplies. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $15,639.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 19, 2024, with a completion date of August 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,012.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication. This award does not have...
This is a $1,339.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a medical product, with a period of performance through June 24, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTQB6
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $2,444.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML medical products, with a period of performance through June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA, which provides comprehensive global pharmaceutical support for military healthcare programs. The contract is not designated as a set-aside.

Generated 9/16/25, 10:05 AM